| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | 164,6 k € | |||||||||
| Gross margin | 373,9 k € | +4.9% | 356,4 k € | +18.2% | 301,6 k € | -39.0% | 494,4 k € | -19.6% | 614,9 k € | +103.3% | 302,5 k € | -15.2% | 356,8 k € | +51.8% | 235,1 k € | +164.9% | 88,8 k € | |
| EBITDA | 373,6 k € | +4.9% | 356,2 k € | +18.2% | 301,5 k € | -39.0% | 494,3 k € | -19.6% | 614,8 k € | +103.3% | 302,3 k € | -14.7% | 354,3 k € | +52.3% | 232,6 k € | +165.3% | 87,7 k € | |
| Operating profit | 359,3 k € | +5.0% | 342,2 k € | +19.1% | 287,2 k € | -41.3% | 489,5 k € | -20.1% | 612,9 k € | +104.2% | 300,1 k € | -14.7% | 351,8 k € | +52.1% | 231,4 k € | +164.6% | 87,4 k € | |
| Profit/loss | 273,4 k € | +4.8% | 261,0 k € | +18.7% | 219,9 k € | -40.4% | 369,0 k € | -20.0% | 461,5 k € | +109.7% | 220,1 k € | -14.1% | 256,3 k € | +66.8% | 153,6 k € | +153.6% | 60,6 k € | |
| Equity | 515,7 k € | -4.9% | 542,3 k € | +92.8% | 281,3 k € | -41.3% | 478,9 k € | +335.9% | 109,9 k € | -84.5% | 708,4 k € | +45.1% | 488,3 k € | +109.7% | 232,8 k € | +194.1% | 79,2 k € | |
| Total assets | 534,8 k € | -2.6% | 548,8 k € | +33.9% | 409,7 k € | -20.2% | 513,6 k € | -5.2% | 541,9 k € | -24.1% | 713,5 k € | +35.2% | 527,9 k € | +104.4% | 258,3 k € | +150.5% | 103,1 k € | |
| Cash | 247,7 k € | +4.4% | 237,4 k € | +424.3% | 45,3 k € | -76.9% | 195,7 k € | -40.6% | 329,7 k € | -44.0% | 589,2 k € | +52.7% | 385,7 k € | +147.7% | 155,7 k € | +227.1% | 47,6 k € | |
| Debts | 7,9 k € | +24.2% | 6,3 k € | -95.1% | 128,4 k € | +269.9% | 34,7 k € | -92.0% | 431,9 k € | +8229.0% | 5,2 k € | -86.9% | 39,6 k € | +57.8% | 25,1 k € | +4.9% | 23,9 k € | |
Private limited company · Maarkedal · incorporated on 28/12/2016
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. H. Segers, klinisch bioloog is a Private limited company incorporated in 2016. Its main activity is: Other human health activities. Its registered office is in Maarkedal.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette